Ovarian Cancer, the Revised FIGO Staging System, and the Role of Imaging.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  AJR. American journal of roentgenology

• Publication date

  2016-04-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.2214/AJR.15.15199PMID 27042752
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epithelial ovarian cancer

  2018cited by this paper
• FIGO 2013 staging system for ovarian cancer: what is new in comparison to the 1988 staging system?

  2015cited by this paper
• Comparison of MRI and CT for Predicting the Peritoneal Cancer Index (PCI) Preoperatively in Patients Being Considered for Cytoreductive Surgical Procedures

  2015cited by this paper
• Stage IIIC Ovarian/Peritoneal Serous Carcinoma: A Heterogeneous Group of Patients With Different Prognoses

  2014cited by this paper
• Staging classification for cancer of the ovary, fallopian tube, and peritoneum

  2014cited by this paper
• 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer.

  2014cited by this paper
• Cancer statistics, 2014

  2014cited by this paper
• Assignment of primary site in high‐grade serous tubal, ovarian and peritoneal carcinoma: a proposal

  2014cited by this paper
• ACR Appropriateness Criteria® Staging and Follow-Up of Ovarian Cancer.

  2013cited by this paper
• Ovarian Serous Tumors of Low Malignant Potential With Nodal Low-grade Serous Carcinoma

  2012cited by this paper
• Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features

  2012cited by this paper
• Optimal primary surgical treatment for advanced epithelial ovarian cancer.

  2011cited by this paper
• Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin?

  2010cited by this paper
• Peritoneal carcinomatosis from ovarian cancer: the role of CT and [18F]FDG-PET/CT

  2010cited by this paper
• Prognostic Factors for Stage I Ovarian Carcinoma

  2010cited by this paper
• Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI.

  2010cited by this paper
• Upstaging pathologic stage I ovarian carcinoma based on dense adhesions is not warranted: a clinicopathologic study of 84 patients originally classified as FIGO stage II.

  2010cited by this paper
• Adnexal Mass Vascularity Assessed by 3-Dimensional Power Doppler: Does It Add to the Risk of Malignancy Index in Prediction of Ovarian Malignancy?: Four Hundred-Case Study

  2009cited by this paper
• Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

  2009cited by this paper
• Clear Cell Carcinoma Compared to Serous Carcinoma in Early Ovarian Cancer: Same Prognosis in a Large Randomized Trial

  2009cited by this paper
• Influence of Intraoperative Capsule Rupture on Outcomes in Stage I Epithelial Ovarian Cancer

  2009cited by this paper
• Prognostic factors for high‐risk early‐stage epithelial ovarian cancer

  2008cited by this paper
• Metastatic lymph node number in epithelial ovarian carcinoma: does it have any clinical significance?

  2008cited by this paper
• Impacto clínico de la PET-FDG en pacientes con sospecha de recurrencia de cáncer de ovario

  2008cited by this paper
• [Clinical impact of FDG-PET in patients with suspected recurrent ovarian cancer].

  2008cited by this paper
• Impact of FDG PET-CT imaging on the decision making in the biologic suspicion of ovarian carcinoma recurrence.

  2008cited by this paper
• [Clinical impact of FDG-PET in patients with suspected recurrent ovarian cancer].

  2008cited by this paper
• Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT

  2008cited by this paper
• Adnexal masses: accuracy of detection and differentiation with multidetector computed tomography.

  2008cited by this paper
• Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer.

  2008cited by this paper
• Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings

  2007cited by this paper
• Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship

  2007cited by this paper
• Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: Correlation with transvaginal ultrasonography, computed tomography, and histology

  2007cited by this paper
• A new prognostic model for FIGO stage 1 epithelial ovarian cancer.

  2007cited by this paper
• A Practical Approach to the Ultrasound Characterization of Adnexal Masses

  2007cited by this paper
• Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screening

  2007cited by this paper
• Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B.

  2007cited by this paper
• Diagnostic accuracy of FDG PET in the follow-up of platinum-sensitive epithelial ovarian carcinoma

  2007cited by this paper
• [Value of positron emission tomography-CT imaging combined with continual detection of CA125 in serum for diagnosis of early asymptomatic recurrence of epithelial ovarian carcinoma].

  2007cited by this paper
• Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.

  2007cited by this paper
• 18F-FDG PET/CT evaluation of patients with ovarian carcinoma

  2007cited by this paper
• Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer.

  2007cited by this paper
• Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer

  2006cited by this paper
• Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

  2006cited by this paper
• Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?

  2006cited by this paper
• Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial.

  2005cited by this paper
• Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year.

  2005cited by this paper
• 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).

  2005cited by this paper
• Lymphatic metastasis in epithelial ovarian carcinoma with respect to clinicopathological variables.

  2005cited by this paper
• Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer.

  2005cited by this paper
• Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer.

  2004cited by this paper
• Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum Presenting as Lymphadenopathy

  2004cited by this paper
• Clinical results of CsI-detector-based dual-exposure dual energy in chest radiography

  2003cited by this paper
• Carcinoma of the Ovary

  2003cited by this paper
• Thin Section Dual‐Phase Multidetector‐Row Computed Tomography Detection of Peritoneal Metastases in Gynecologic Cancers

  2003cited by this paper
• Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer

  2003cited by this paper
• Multidetector CT of peritoneal carcinomatosis from ovarian cancer.

  2003cited by this paper
• US of the peritoneum.

  2003cited by this paper
• Pathology and classification of ovarian tumors

  2003cited by this paper
• Serous Borderline Tumors of the Ovary: A Long-Term Follow-Up Study of 137 Cases, Including 18 With a Micropapillary Pattern and 20 With Microinvasion

  2002cited by this paper
• Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer.

  2002cited by this paper
• Abdominal recurrence of ovarian cancer: value of abdominal MR in patients with positive CA125 and negative CT.

  2002cited by this paper
• Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings.

  2001cited by this paper
• Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma.

  2001cited by this paper
• Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer

  2001cited by this paper
• Staging of advanced ovarian cancer: comparison of imaging modalities--report from the Radiological Diagnostic Oncology Group.

  2000cited by this paper
• Ovarian cancer: epidemiology, biology, and prognostic factors.

  2000cited by this paper
• Complex adnexal masses: detection and characterization with MR imaging--multivariate analysis.

  2000cited by this paper
• Malignant Germ Cell Tumors of the Ovary

  2000cited by this paper
• Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma

  2000cited by this paper
• A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography

  2000cited by this paper
• Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis--report of the Radiology Diagnostic Oncology Group.

  1999cited by this paper
• CT of epithelial ovarian tumors.

  1999cited by this paper
• The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: impact of nodal metastasis on patient survival.

  1999cited by this paper
• Managing hereditary ovarian cancer risk

  1999cited by this paper
• Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament: Atlas of Tumor Pathology

  1999cited by this paper
• Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

  1998cited by this paper
• Patients with ovarian carcinoma upstaged to Stage III after systematic lymphadenctomy have similar survival to Stage I/II patients and superior survival to other Stage III patients

  1998cited by this paper
• Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features.

  1998cited by this paper
• Transvaginal ultrasonographic characterization of ovarian masses: comparison of five scoring systems in a multicenter study

  1997cited by this paper
• Transvaginal color Doppler sonography and conventional sonography in the preoperative assessment of adnexal masses

  1997cited by this paper
• Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre‐operative diagnosis of pelvic masses

  1996cited by this paper
• Natural history and prognosis of untreated stage I epithelial ovarian carcinoma.

  1996cited by this paper
• Life‐time risk of different cancers in hereditary non‐polyposis colorectal cancer (hnpcc) syndrome

  1995cited by this paper
• Ovarian cancer: staging with CT and MR imaging.

  1995cited by this paper
• The influence of tumor grade, distribution, and extent of carcinomatosis in minimal residual stage III epithelial ovarian cancer after optimal primary cytoreductive surgery.

  1994cited by this paper
• Transvaginal ultrasonographic characterization of ovarian masses with an improved, weighted scoring system.

  1994cited by this paper
• Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1994cited by this paper
• The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma.

  1994cited by this paper
• Rates and Risks of Ovarian Cancer in Subgroups of White Women in the United States

  1994cited by this paper
• Molecular genetics for the clinician

  1993cited by this paper
• The epidemiology of ovarian cancer.

  1992cited by this paper
• A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer

  1991cited by this paper
• Transvaginal Sonographic Characterization of Ovarian Disease: Evaluation of a New Scoring System to Predict Ovarian Malignancy

  1991cited by this paper
• Peritoneal carcinomatosis with ascites.

  1991cited by this paper
• A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer

  1990cited by this paper
• From the archives of the AFIP. Malignant germ cell tumors of the ovary: radiologic-pathologic correlation.

  1990cited by this paper
• Prognostic Factors in Patients With Stage I Epithelial Ovarian Cancer

  1990cited by this paper
• Germ cell tumors of the ovary.

  1987cited by this paper
• Factors influencing survival in carcinoma of the ovary. Study from a well‐defined swedish population

  1985cited by this paper

• Habitat radiomics based on CT for assessing BRCA mutation status in patients with high-grade serous ovarian cancer: a multicenter study.

  2026cites this paper
• m6A modification and its clinical applications in gynaecological cancer

  2026cites this paper
• Survival prediction and risk stratification in R0-resected ovarian cancer: a multi-modal deep learning approach

  2026cites this paper
• CT deep learning radiomics and genomics for predicting staging of epithelial ovarian cancer.

  2026cites this paper
• Regulation of autophagy by oncogene DJ1 via the JNK signaling pathway in human ovarian cancer cells

  2025cites this paper
• Automated grading and staging of ovarian cancer using deep learning on the transmission optical microscopy bright-field images of thin biopsy tissue samples

  2025cites this paper
• Cáncer de ovario

  2025cites this paper
• Preoperative prediction of lymph node metastasis in patients with ovarian cancer using contrast-enhanced computed tomography-based intratumoral and peritumoral radiomics features

  2025cites this paper
• Habitat-based radiomics for preoperative differentiation between early-stage serous borderline ovarian tumors and malignant ovarian tumors

  2025cites this paper
• A Decade of Ovarian Cancer in Indonesia: Epidemiology and Survival Analysis from 2010 to 2020

  2025cites this paper
• Res-ECA-UNet++: an automatic segmentation model for ovarian tumor ultrasound images based on residual networks and channel attention mechanism

  2025cites this paper
• Immature teratomas remain difficult to diagnose: A cross-sectional study

  2025cites this paper
• Comparative diagnostic performance of the early‐stage ovarian malignancy score versus other risk prediction models in early‐stage ovarian cancer: A Vietnamese prospective cohort study

  2025cites this paper
• CT-based radiomics model for noninvasive prediction of progression-free survival in high-grade serous ovarian carcinoma: a multicenter study incorporating preoperative and postoperative clinical factors

  2025cites this paper
• Exon 4 and intron 4 TP53 are both methylated in advanced-stage ovarian carcinomas

  2025cites this paper
• Juvenile granulosa cell tumor in a teenager: a case report

  2025cites this paper
• Contrast-enhanced CT radiomics for preoperative prediction of stage in epithelial ovarian cancer: a multicenter study

  2024cites this paper
• Adenocarcinoma of Mullerian Origin Found Through an Elective Inguinal Hernia Resection: A Case Report

  2024cites this paper
• A Perspective Review: Analyzing Collagen Alterations in Ovarian Cancer by High-Resolution Optical Microscopy

  2024cites this paper
• Imaging of Peritoneal Metastases in Ovarian Cancer Using MDCT, MRI, and FDG PET/CT: A Systematic Review and Meta-Analysis

  2024cites this paper
• Ginsenoside RG3-loaded microneedles for in situ treatment of ovarian cancer

  2024cites this paper
• Endometriosis-Related Ovarian Cancer: Where Are We Now? A Narrative Review towards a Pragmatic Approach

  2024cites this paper
• Protocol for identifying metabolite biomarkers in patient uterine fluid for early ovarian cancer detection

  2024cites this paper
• A modified diffusion-weighted MRI-based model from the radiologist's perspective: improved performance in determining the surgical resectability for advanced high-grade serous ovarian cancer.

  2024cites this paper
• Development and validation of an ultrasound‑based radiomics nomogram to predict lymph node status in patients with high-grade serous ovarian cancer: a retrospective analysis

  2024cites this paper
• Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements

  2024cites this paper
• The dual roles of circRNAs in Wnt/β-Catenin signaling and cancer progression.

  2024cites this paper
• Radiomics nomogram for preoperative differentiation of early-stage serous borderline ovarian tumors and serous malignant ovarian tumors

  2024cites this paper
• A Comprehensive Review of Current Trends in the Diagnosis and Treatment of Ovarian Germ Cell Tumors

  2024cites this paper
• Diagnostic value of cross-sectional imaging modalities in assessment of peritoneal carcinomatosis

  2024cites this paper
• The tipping point: Key oncologic imaging findings resulting in critical changes in the management of malignant genitourinary and gynecological tumors.

  2024cites this paper
• Trials of interventions for ovarian and testicular germ cell tumors registered in ClinicalTrials.gov: A cross-sectional study.

  2024cites this paper
• Prognostic Impact of Tumor-Infiltrating Immune Cells on Efficacy of Neoadjuvant Chemotherapy in Patients with Advanced or Metastatic Ovarian Cancer: A Retrospective Study

  2024cites this paper
• Diagnostic accuracy and clinical value of [68Ga]Ga-FAPI-46 PET/CT for staging patients with ovarian cancer: study protocol for a prospective clinical trial

  2024cites this paper
• Machine learning‐derived identification of prognostic signature for improving prognosis and drug response in patients with ovarian cancer

  2023cites this paper
• An Unusual Presentation: High-Grade Serous Carcinoma of the Fallopian Tube Manifesting with Altered Mental Status Secondary to a Single Brain Metastasis - A Case Report and Review of The Literature.

  2023cites this paper
• High density of CXCL12-positive immune cell infiltration predicts chemosensitivity and recurrence-free survival in ovarian carcinoma

  2023cites this paper
• Pendekatan Klinis Massa Ovarium di Fasilitas Kesehatan Tingkat Pertama dengan USG menggunakan penilaian IOTA

  2023cites this paper
• Current Update on PET/MRI in Gynecological Malignancies—A Review of the Literature

  2023cites this paper
• Is Computed Tomography Reliable for Detecting Lymph Node Metastasis in Advanced Epithelial Ovarian Cancer?

  2023cites this paper
• Cardiovascular outcomes trial data from EMPA‐REG OUTCOME, CAROLINA and CARMELINA: Assessment of a novel staging system for type 2 diabetes

  2023cites this paper
• Changes in Nucleolin Expression during Malignant Transformation Leading to Ovarian High-Grade Serous Carcinoma

  2023cites this paper
• Prediction of the survival of patients with advanced‐stage ovarian cancer patients undergoing interval cytoreduction with the use of computed tomography reevaluation after neoadjuvant chemotherapy

  2023cites this paper
• CT-based deep learning segmentation of ovarian cancer and the stability of the extracted radiomics features

  2023cites this paper
• Diagnostic performance of noninvasive imaging using computed tomography, magnetic resonance imaging, and positron emission tomography for the detection of ovarian cancer: a meta-analysis

  2023cites this paper
• Emphysematous pyelonephritis after urinary diversion by percutaneous nephrostomy in patient with advanced cervical cancer: A case report

  2023cites this paper
• Real-world Efficacy and Safety of Bevacizumab for Advanced or Recurrent Müllerian Cancer: A Single-institutional Experience

  2023cites this paper
• Correlation of systemic immune-inflammatory response index with clinical data in patients with malignant ovarian tumor.

  2023cites this paper
• Prognostic value of preoperative serological biomarkers in patients undergoing cytoreductive surgery for ovarian cancer peritoneal metastases

  2023cites this paper
• MR Imaging of Gynecologic Tumors: Pearls, Pitfalls, and Tumor Mimics.

  2023cites this paper
• The Validation of a Precursor Lesion of Epithelial Ovarian Cancer in Fancd2-KO Mice

  2023cites this paper
• MR Imaging of Epithelial Ovarian Neoplasms Part II: Malignant.

  2023cites this paper
• Prediction model of adnexal masses with complex ultrasound morphology

  2023cites this paper
• Enhancement of sonodynamic treatment of ovarian cancer based on Pt-B-P ternary nanoparticles.

  2023cites this paper
• Puberté normale et pathologique

  2023cites this paper
• How do serum lipid levels change and influence progression-free survival in epithelial ovarian cancer patients receiving bevacizumab treatment?

  2023cites this paper
• Inguinal nodal clinical target volume delineation based on analysis of anatomical locations of normal and metastatic lymph nodes in pelvic malignant tumors.

  2023cites this paper
• MRI appearances of stage IA ovarian carcinoma.

  2023cites this paper
• Deep learning for the ovarian lesion localization and discrimination between borderline and malignant ovarian tumors based on routine MR imaging

  2023cites this paper
• Deep learning-based segmentation of epithelial ovarian cancer on T2-weighted magnetic resonance images

  2023cites this paper
• Utility of Matrix Metalloproteinases in the Diagnosis, Monitoring and Prognosis of Ovarian Cancer Patients

  2022cites this paper
• DIFFUSION WEIGHTED IMAGING AND APPARENT DIFFUSION COEFFICIENT IN CHARACTERIZATION OF COMPLEX OVARIAN MASSES IN SOUTH INDIAN POPULATION

  2022cites this paper
• Incidence and Survival Rates for Female Malignant Germ Cell Tumors: An Institutional Review

  2022cites this paper
• Prognostic Value of Peritoneal Cancer Index After Complete Cytoreductive Surgery in Advanced Ovarian Cancer

  2022cites this paper
• Surgery in Advanced Ovary Cancer: Primary versus Interval Cytoreduction

  2022cites this paper
• The functional multipotency of transforming growth factor β signaling at the intersection of senescence and cancer

  2022cites this paper
• Pubertad normal y patológica

  2022cites this paper
• Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine

  2022cites this paper
• Immature Teratoma With Metastatic Gliosis

  2022cites this paper
• A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis

  2022cites this paper
• Analgesia for Gynecologic Oncologic Surgeries: A Narrative Review

  2022influential citation
• Two-dimensional and three-dimensional T2 weighted imaging-based radiomic signatures for the preoperative discrimination of ovarian borderline tumors and malignant tumors

  2022cites this paper
• Magnetic resonance imaging in the diagnosis of malignant gynaecological tumours

  2022cites this paper
• Identification of an Amino Acid Metabolism Signature Participating in Immunosuppression in Ovarian Cancer

  2022cites this paper
• Clinical efficacy of peritoneal perfusion of bevacizumab in combination with venous chemotherapy of paclitaxel and Cis-platinum on the late-stage ovarian cancer and the effect on levels of VEGF, MIF, HE4 and CA125

  2022cites this paper
• Magnetic Resonance Imaging and Diffusion Weighted Imaging-Based Histogram in Predicting Mesenchymal Transition High-Grade Serous Ovarian Cancer.

  2022cites this paper
• Multivariate logistic regression analysis of the correlation between five biomarkers and ovarian cancer in patients with intermediate-risk: A prospective cross-sectional study

  2022cites this paper
• Pre-Treatment CRP-Albumin-Lymphocyte Index (CALLY Index) as a Prognostic Biomarker of Survival in Patients with Epithelial Ovarian Cancer

  2022cites this paper
• Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer

  2022cites this paper
• Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment

  2022cites this paper
• Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer

  2022cites this paper
• A CT-based radiomics nomogram for predicting early recurrence in patients with high-grade serous ovarian cancer.

  2021cites this paper
• Diagnostic imaging in gynecology.

  2021cites this paper
• Ovarian Cancer as Random Finding in Laparoscopy

  2021cites this paper
• MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors

  2021cites this paper
• Role of Ultrasonography and MRI in Diagnosing Different Types of Adnexal Masses

  2021cites this paper
• Differential expression of PD-L1 between primary and metastatic epithelial ovarian cancer and its clinico-pathological correlation

  2021cites this paper
• Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group

  2021cites this paper
• Radiomics based on multisequence magnetic resonance imaging for the preoperative prediction of peritoneal metastasis in ovarian cancer

  2021cites this paper
• Spatial cytotoxic and memory T cells in tumor predict superior survival outcomes in patients with high‐grade serous ovarian cancer

  2021cites this paper
• Comprehending the Proteomic Landscape of Ovarian Cancer: A Road to the Discovery of Disease Biomarkers

  2021cites this paper
• Current update on malignant epithelial ovarian tumors

  2021cites this paper
• Comparison of Peritoneal Carcinomatosis Scoring Methods in Predicting Resectability and Prognosis in Gynecologic Malignancies

  2021cites this paper
• Factors Influencing the Discordancy Between Intraoperative Frozen Sections and Final Paraffin Pathologies in Ovarian Tumors

  2021cites this paper
• Primary peritoneal mucinous cystadenocarcinoma mimicking possible recurrent ovarian mucinous cystadenoma: coincidental pathology or a spectrum of disease?

  2021cites this paper
• Psoas muscle index at the fifth lumbar vertebra as a predictor of survival in epithelial ovarian cancers

  2021cites this paper
• Elevated LINC00909 Promotes Tumor Progression of Ovarian Cancer via Regulating the miR-23b-3p/MRC2 Axis

  2021cites this paper
• Clues to the diagnosis of borderline ovarian tumours: An imaging guide.

  2021cites this paper
• Trousseau’s syndrome associated with an ovarian borderline tumour

  2021cites this paper
• Problems in gynaecologic oncology in girls and young women—an outline of selected issues

  2021cites this paper